CDK2 and gastric cancer: investigated the effects of calycosin (47 μM) on increased p27 and p21 expression levels and cell cycle at G0/G1 with lowering cyclin D1, cyclin E, and CDK2, CDK4, and CDK6 levels, in gastric cancer.90